Goldman Sachs Group Inc set a €29.00 ($34.12) price target on Evonik Industries AG (FRA:EVK) in a research note released on Monday, November 6th. The brokerage currently has a neutral rating on the stock.
EVK has been the topic of several other research reports. Nord/LB set a €31.00 ($36.47) target price on Evonik Industries and gave the stock a neutral rating in a research report on Friday, November 3rd. Deutsche Bank AG set a €32.00 ($37.65) target price on Evonik Industries and gave the stock a neutral rating in a research report on Tuesday, September 12th. J P Morgan Chase & Co set a €32.00 ($37.65) target price on Evonik Industries and gave the stock a neutral rating in a research report on Friday, August 4th. Baader Bank set a €41.00 ($48.24) target price on Evonik Industries and gave the stock a buy rating in a research report on Thursday, August 3rd. Finally, DZ Bank AG reissued a neutral rating on shares of Evonik Industries in a research report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of €33.38 ($39.27).
Evonik Industries (FRA EVK) traded up €0.09 ($0.11) during mid-day trading on Monday, reaching €31.47 ($37.02). The company’s stock had a trading volume of 395,366 shares. Evonik Industries has a 52 week low of €25.71 ($30.25) and a 52 week high of €32.97 ($38.79).
TRADEMARK VIOLATION NOTICE: “Goldman Sachs Group Inc Analysts Give Evonik Industries AG (FRA:EVK) a €29.00 Price Target” was published by BBNS and is the sole property of of BBNS. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://baseballnewssource.com/markets/goldman-sachs-group-inc-the-analysts-give-evonik-industries-ag-evk-a-29-00-price-target/1761616.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with our FREE daily email newsletter.